Leidos (NYSE:LDOS) Issues Earnings Results

Leidos (NYSE:LDOS) released its earnings results on Tuesday. The aerospace company reported $2.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.59, RTT News reports. The firm had revenue of $3.98 billion during the quarter, compared to the consensus estimate of $3.82 billion. Leidos had a net margin of 1.29% and a return on equity of 22.92%. The company’s revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.47 EPS. Leidos updated its FY 2024 guidance to 8.400-8.800 EPS and its FY24 guidance to $8.40-8.80 EPS.

Leidos Stock Performance

NYSE LDOS opened at $140.22 on Wednesday. The company’s 50 day simple moving average is $128.08 and its two-hundred day simple moving average is $114.53. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.34 and a quick ratio of 1.24. Leidos has a 1 year low of $76.58 and a 1 year high of $140.91. The stock has a market capitalization of $18.95 billion, a PE ratio of 98.75, a P/E/G ratio of 1.82 and a beta of 0.70.

Leidos Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Investors of record on Tuesday, May 14th will be issued a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date of this dividend is Friday, June 14th. Leidos’s dividend payout ratio (DPR) is presently 107.04%.

Insider Activity

In related news, Director David G. Fubini sold 7,874 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the completion of the transaction, the director now directly owns 14,696 shares in the company, valued at $1,879,471.44. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, Director Gary Stephen May sold 2,745 shares of the stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $124.49, for a total value of $341,725.05. Following the transaction, the director now owns 11,352 shares of the company’s stock, valued at approximately $1,413,210.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director David G. Fubini sold 7,874 shares of Leidos stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $127.89, for a total transaction of $1,007,005.86. Following the sale, the director now directly owns 14,696 shares of the company’s stock, valued at $1,879,471.44. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on LDOS. Wells Fargo & Company increased their price objective on Leidos from $137.00 to $147.00 and gave the company an “overweight” rating in a report on Thursday, April 4th. Royal Bank of Canada increased their price target on Leidos from $105.00 to $120.00 and gave the stock a “sector perform” rating in a research note on Wednesday, February 14th. StockNews.com cut Leidos from a “strong-buy” rating to a “buy” rating in a research note on Friday, April 26th. Argus increased their target price on shares of Leidos from $120.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Finally, Truist Financial boosted their price target on shares of Leidos from $135.00 to $150.00 and gave the company a “buy” rating in a research report on Tuesday, April 9th. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, Leidos has an average rating of “Moderate Buy” and an average price target of $132.42.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.